OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Cachexia Sarcopenia and Muscle is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Impaired muscle function, including its decline, is related to greater long‐term late‐life dementia risk in older women	627
Muscle Mass Index Decline as a Predictor of Lung Function Reduction in the General Population	335
Lonafarnib Protects Against Muscle Atrophy Induced by Dexamethasone	234
Acute Sarcopenia: Systematic Review and Meta‐Analysis on Its Incidence and Muscle Parameter Shifts During Hospitalisation	161
Testosterone Modulation of Muscle Transcriptomic Profile During Lifestyle Therapy in Older Men with Obesity and Hypogonadism	143
Enhancing oncological care: A guide to setting up a new multidisciplinary cancer cachexia clinic within a tertiary centre	109
Prognostic utility of self‐reported sarcopenia (SARC‐F) in the Multiethnic Cohort	106
Protein intake and bone mineral density: Cross‐sectional relationship and longitudinal effects in older adults	103
A new computed tomography‐based approach to quantify swallowing muscle volume by measuring tongue muscle area in a single slice	99
TRIM16 facilitates SIRT‐1‐dependent regulation of antioxidant response to alleviate age‐related sarcopenia	94
Electrical stimulated GLUT4 signalling attenuates critical illness‐associated muscle wasting	92
Test–retest reliability and follow‐up of muscle magnetic resonance elastography in adults with and without muscle diseases	89
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021	89
Different outcomes of endurance and resistance exercise in skeletal muscles of Oculopharyngeal muscular dystrophy	88
Application of the D₃‐creatine muscle mass assessment tool to a geriatric weight loss trial: A pilot study	87
Maternal vitamin D deficiency affects the morphology and function of glycolytic muscle in adult offspring rats	83
Body composition reference ranges in community‐dwelling adults using dual‐energy X‐ray absorptiometry: the Australian Body Composition (ABC) Study	80
Issue Information	77
Molecular mechanisms of post‐burn muscle wasting and the therapeutic potential of physical exercise	76
Issue Information	75
With Appreciation	74
Comment on “Sarcopenia is associated with a greater risk of polypharmacy and number of medications: a systematic review and meta‐analysis” by Prokopidis et al.	73
Doubly labelled water‐calibrated energy intake associations with mortality risk among older adults	72
Intramuscular tetanus neurotoxin reverses muscle atrophy: a randomized controlled trial in dogs with spinal cord injury	70
Resistance and endurance exercise training improves muscle mass and the inflammatory/fibrotic transcriptome in a rhabdomyosarcoma model	64

Urinary metabolomic biomarker candidates for skeletal muscle wasting in patients with rheumatoid arthritis	64
The combined effect of cardiorespiratory and muscular fitness on the incidence of metabolic syndrome before midlife	64
Issue Information	63
Different effects of low muscle mass on the risk of non‐alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort	62
Issue Information	61
Associations between dynapenia, cardiovascular hospitalizations, and all‐cause mortality among patients on haemodialysis	60
Muscle strength, but not body mass index, is associated with mortality in patients with non‐alcoholic fatty liver disease	57
Tumour catabolism independent of malnutrition and inflammation in upper GI cancer patients revealed by longitudinal metabolomics	57
The association between weight change after gastric cancer surgery and type 2 diabetes risk: A nationwide cohort study	56
Are measures and related symptoms of cachexia recorded as outcomes in gastrointestinal cancer chemotherapy clinical trials?	56
	56
Apples to apples? Discordant definitions still hinder evidence‐based treatments for sarcopenia	55
The relationship between weight gain during chemotherapy and outcomes in patients with advanced non‐small cell lung cancer	54
Does COVID‐19‐related cachexia mimic cancer‐related cachexia? Examining mechanisms, clinical biomarkers, and potential targets for clinical management	53
Short‐term disuse does not affect postabsorptive or postprandial muscle protein fractional breakdown rates	53
Cross‐sectional and longitudinal associations between body flexibility and sarcopenia	52
A prospective clinical study on the mechanisms underlying critical illness myopathy—A time‐course approach	52
The p97‐Nploc4 ATPase complex plays a role in muscle atrophy during cancer and amyotrophic lateral sclerosis	50
Leisure‐time physical activity and sarcopenia among older adults from low‐ and middle‐income countries	49
Cross‐sectional and longitudinal association between atrial fibrillation and sarcopenia: Findings from the Korean frailty and aging cohort study	49
Sarcopenia knowledge of geriatric rehabilitation patients is low while they are willing to start sarcopenia treatment: EMPOWER‐GR	48
Abstracts	48
Comment on “Hand grip strength‐based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancer” by Xie et al. — The authors reply	47
Comment on “Effects of Vivifrail multicomponent intervention on functional capacity” by Casas‐Herrero et al.—The authors reply	46
Prognostic impact of cachexia by multi‐assessment in older adults with heart failure: FRAGILE‐HF cohort study	46
Impact of high‐intensity interval training with or without l‐citrulline on physical performance, skeletal muscle, and adipose tissue in obese older adults	45
Muscle quality and spine fractures	45
The Authors reply: Comment on: “Experimental ischaemic stroke induces transient cardiac atrophy” by Veltkamp et al.	45
Histopathological correlations and fat replacement imaging patterns in recessive limb‐girdle muscular dystrophy type 12	45
Scoring the physical frailty phenotype of patients with heart failure	45
Skeletal muscle mitoribosomal defects are linked to low bone mass caused by bone marrow inflammation in male mice	44
Handgrip strength and all‐cause dementia incidence and mortality: findings from the UK Biobank prospective cohort study	44
Plasma neurofilament light levels associate with muscle mass and strength in middle‐aged and older adults: findings from GenoFit	44
Upregulation of cluster of differentiation 36 mRNA expression in peripheral blood mononuclear cells correlates with frailty severity in older adults	44
Clinical frailty, and not features of acute infection, is associated with late mortality in COVID‐19: a retrospective cohort study	44
Population‐based cohort imaging: skeletal muscle mass by magnetic resonance imaging in correlation to bioelectrical‐impedance analysis	43
Is slowness a better discriminator of disability than frailty in older adults?	43
Human pancreatic tumour organoid‐derived factors enhance myogenic differentiation	43
Mapping ongoing nutrition intervention trials in muscle, sarcopenia, and cachexia: a scoping review of future research	43
Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series	43
Issue Information	42
Comment on ‘Allograft function and muscle mass evolution after kidney transplantation’ by Gaillard et al.: The authors reply	41
Effects of S‐pindolol in mouse pancreatic and lung cancer cachexia models	41
EXT418, a novel long‐acting ghrelin, mitigates Lewis lung carcinoma induced cachexia in mice	41
Cannabinoid interventions for improving cachexia outcomes in cancer: a systematic review and meta‐analysis	40
Water T2 could predict functional decline in patients with dysferlinopathy	39
Issue Information	39
Sarcopenia as a prognostic indicator of liver cirrhosis	39
Author Index	39
Impact of protocol‐based physiotherapy on insulin sensitivity and peripheral glucose metabolism in critically ill patients	38

Increased odds of having the metabolic syndrome with greater fat‐free mass: counterintuitive results from the National Health and Nutrition Examination Survey database	38
Prospective trial to evaluate the prognostic value of different nutritional assessment scores for survival in pancreatic ductal adenocarcinoma (NURIMAS Pancreas SURVIVAL)	38
Radiation induces long‐term muscle fibrosis and promotes a fibrotic phenotype in fibro‐adipogenic progenitors	37
Association of weight change and in‐hospital mortality in patients with repeated hospitalization for heart failure	37
Matrisome, innervation and oxidative metabolism affected in older compared with younger males with similar physical activity	37
Diagnosis of sarcopenia by evaluating skeletal muscle mass by adjusted bioimpedance analysis validated with dual‐energy X‐ray absorptiometry	36
Effects of measurement protocols and repetitions on handgrip strength weakness and asymmetry in patients with cancer	36
Percentile‐based averaging and skeletal muscle gauge improve body composition analysis: validation at multiple vertebral levels	36
TMEM182 interacts with integrin beta 1 and regulates myoblast differentiation and muscle regeneration	36
Clinically meaningful change for the chair stand test: monitoring mobility in integrated care for older people	36
Impact of resistance training and chicken intake on vascular and muscle health in elderly women	36
Kidney function in cachexia and sarcopenia: Facts and numbers	36
Anorexia of Ageing, an Underappreciated Perioperative Concern?	35
Distinct Gut Microbiota Profiles in Normal Weight Obesity and Their Association With Cardiometabolic Diseases: Results From Two Independent Cohort Studies	35
NLRP3 Inflammasome Activation and Altered Mitophagy Are Key Pathways in Inclusion Body Myositis	35
Mitochondrial dysfunction in skeletal muscle contributes to the development of acute insulin resistance in mice	35
Specific miRNAs are associated with human cancer cachexia in an organ‐specific manner	34
Pyruvate dehydrogenase B regulates myogenic differentiation via the FoxP1–Arih2 axis	34
Inflammation‐associated intramyocellular lipid alterations in human pancreatic cancer cachexia	34
High physical activity alleviates the adverse effect of higher sedentary time on the incidence of chronic kidney disease	34
Improved therapeutic approach for spinal muscular atrophy via ubiquitination‐resistant survival motor neuron variant	34
The mediation roles of intermuscular fat and inflammation in muscle mitochondrial associations with cognition and mobility	34
Protein intake in cancer: Does it improve nutritional status and/or modify tumour response to chemotherapy?	34
Computed tomography‐determined skeletal muscle density predicts 3‐year mortality in initial‐dialysis patients in China	34
Scaling of computed tomography body composition to height: relevance of height‐normalized indices in patients with colorectal cancer	34
Growth hormone secretagogue receptor‐1a mediates ghrelin's effects on attenuating tumour‐induced loss of muscle strength but not muscle mass	33
Comparison of the impact of longitudinal body mass index changes on cardiac arrest risk between normal and overweight populations	33
Improved endurance capacity of diabetic mice during SGLT2 inhibition: Role of AICARP, an AMPK activator in the soleus	33
Sphingomyelinase activity promotes atrophy and attenuates force in human muscle fibres and is elevated in heart failure patients	32
Decoding the transcriptome of denervated muscle at single‐nucleus resolution	32
Sarcopenia is associated with a greater risk of polypharmacy and number of medications: a systematic review and meta‐analysis	32
Phenotypic features of cancer cachexia‐related loss of skeletal muscle mass and function: lessons from human and animal studies	31
Pilot clinical trial of macimorelin to assess safety and efficacy in patients with cancer cachexia	31
The age‐related obesity paradigm: results from two large prospective cohort studies	30
Preserved thenar muscles in non‐ambulant Duchenne muscular dystrophy patients	30
Prediabetes is an independent risk factor for sarcopenia in older men, but not in older women: the Bunkyo Health Study	30
Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshop	30
Effects and tolerability of exercise therapy modality on cardiorespiratory fitness in lung cancer: a randomized controlled trial	30
Serum creatinine to cystatin C ratio reflects preoperative and early postoperative walking ability in older patients with hip fracture	30
Chronic hypoxia impairs skeletal muscle repair via HIF‐2α stabilization	30
A randomized, feasibility trial of an exercise and nutrition‐based rehabilitation programme (ENeRgy) in people with cancer	30
Mouse models of sarcopenia: classification and evaluation	30
Age‐specific and sex‐specific associations of visceral adipose tissue mass and fat‐to‐muscle mass ratio with risk of mortality	29
Sarcopenia and major complications in patients undergoing oncologic colon surgery	29
Increased adipose tissue is associated with improved overall survival, independent of skeletal muscle mass in non‐small cell lung cancer	29
Effects of sarcopenia and frailty on postoperative recovery in elderly patients: A prospective cohort study	29
RhoA/ROCK2 signalling is enhanced by PDGF‐AA in fibro‐adipogenic progenitor cells: implications for Duchenne muscular dystrophy	28
MicroRNAs in obesity, sarcopenia, and commonalities for sarcopenic obesity: a systematic review	28
Sarcopenia and preserved bone mineral density in paediatric survivors of high‐risk neuroblastoma with growth failure	28
Role of skeletal muscle satellite cells in the repair of osteoporotic fractures mediated by β‐catenin	27
Gut microbial characteristics in poor appetite and undernutrition: a cohort of older adults and microbiota transfer in germ‐free mice	27
MicroRNA profiling of different exercise interventions for alleviating skeletal muscle atrophy in naturally aging rats	27
Plasma inflammation‐related biomarkers are associated with intrinsic capacity in community‐dwelling older adults	27
Association between skeletal muscle mass and quality of life in adults with cancer: a systematic review and meta‐analysis	27
Longitudinal relationship between intramuscular adipose tissue of the quadriceps and activities of daily living in older inpatients	27
Effects of a 2‐year exercise training on neuromuscular system health in older individuals with low muscle function	26
m⁶A demethylase ALKBH5 drives denervation‐induced muscle atrophy by targeting HDAC4 to activate FoxO3 signalling	26
Engineered skeletal muscle recapitulates human muscle development, regeneration and dystrophy	26
Sarcopenia‐defining parameters, but not sarcopenia, are associated with cognitive domains in middle‐aged and older European men	26
Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study	26
Home‐based aerobic exercise and resistance training for severe chronic kidney disease: a randomized controlled trial	26
Nicotinamide Phosphoribosyltransferase‐elevated NAD⁺ biosynthesis prevents muscle disuse atrophy by reversing mitochondrial dysfunction	26
Atrophic skeletal muscle fibre‐derived small extracellular vesicle miR‐690 inhibits satellite cell differentiation during ageing	26
Anorexia of aging: An international assessment of healthcare providers' knowledge and practice gaps	26
Probiotic supplementation attenuates age‐related sarcopenia via the gut–muscle axis in SAMP8 mice	25
Exogenous insulin‐like growth factor 1 attenuates cisplatin‐induced muscle atrophy in mice	25
GDNF family receptor alpha‐like antagonist antibody alleviates chemotherapy‐induced cachexia in melanoma‐bearing mice	25
Effects of hormonal changes on sarcopenia in chronic kidney disease: where are we now and what can we do?	25
Pim1 knockout alleviates sarcopenia in aging mice via reducing adipogenic differentiation of PDGFRα⁺ mesenchymal progenitors	25
Physical exercise attenuates age‐related muscle atrophy and exhibits anti‐ageing effects via the adiponectin receptor 1 signalling	25
Artificial‐intelligence‐driven discovery of prognostic biomarker for sarcopenia	25
Impact of regional white matter hyperintensities on specific gait function in Alzheimer's disease and mild cognitive impairment	25
Ambra1 deficiency impairs mitophagy in skeletal muscle	24
Cellular interplay in skeletal muscle regeneration and wasting: insights from animal models	24
Associations between multimorbidity and frailty transitions among older Americans	24
Involvement of Parkin‐mediated mitophagy in the pathogenesis of chronic obstructive pulmonary disease‐related sarcopenia	24
Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the Japanese Lung Cancer Registry Study	24
A systematic review of automated segmentation of 3D computed‐tomography scans for volumetric body composition analysis	24
Dietary phosphate restriction prevents the appearance of sarcopenia signs in old mice	24
Corrigendum to Yang et al. J of Cachexia, Sarcopenia and Muscle, 13, 728–742. https://doi.org/10.1002/jcsm.12882	23

High intramuscular adipose tissue content associated with prognosis and postoperative complications of cancers	23
Association of computed tomography‐derived body composition and complications after colorectal cancer surgery: A systematic review and meta‐analysis	23
Ectopic fat in liver and skeletal muscle is associated with shorter overall survival in patients with colorectal liver metastases	23
Body composition parameters in initial CT imaging of mechanically ventilated trauma patients: Single‐centre observational study	23
Comment on ‘Overall Mortality for Community‐Dwelling Adults Over 50 Years at Risk of Malnutrition’ by Gittins et al.	23
Vitamin D₃supplementation does not enhance the effects of resistance training in older adults	23
Frailty phenotype as mediator between systemic inflammation and osteoporosis and fracture risks: A prospective study	23
Serum carnitine as a biomarker of sarcopenia and nutritional status in preoperative gastrointestinal cancer patients	23
Impact of sarcopenia and phase angle on mortality of the very elderly	23
Inhibition of CILP2 Improves Glucose Metabolism and Mitochondrial Dysfunction in Sarcopenia via the Wnt Signalling Pathway	22
Exploring the utility of ultrasound to assess disuse atrophy in different muscles of the lower leg	22
The authors' reply: ‘Comment on: “Effect of vitamin D monotherapy on indices of sarcopenia in community‐dwelling older adults: a systematic review and meta‐analysis” by Prokopidis et al.’	22
Control of muscle satellite cell function by specific exercise‐induced cytokines and their applications in muscle maintenance	22
Mortality burden of pre‐treatment weight loss in patients with non‐small‐cell lung cancer: A systematic literature review and meta‐analysis	22
The Innovative Role of Nuclear Receptor Interaction Protein in Orchestrating Invadosome Formation for Myoblast Fusion	22
Comment on ‘Change in Physical Activity and Its Association With Decline in Kidney Function: A UK Biobank‐Based Cohort Study’ by Liu et al.	22
Cut‐Off Points for Low Relative 30‐s Sit‐to‐Stand Power and Their Associations With Adverse Health Conditions	22
The relationship between the mode of presentation, CT‐derived body composition, systemic inflammatory grade and survival in colon cancer	22
Furnishing the cachexia landscape: A year of research in JCSM	22
Association of Muscle Strength With All‐Cause Mortality in the Oldest Old: Prospective Cohort Study From 28 Countries	22
Prognostic Value of Systemic Inflammation, Nutritional Status and Sarcopenia in Patients With Amyotrophic Lateral Sclerosis	22
Comment on ‘Diagnosis of Sarcopenia by Evaluating Skeletal Muscle Mass by Adjusted Bioimpedance Analysis Validated With Dual‐Energy X‐Ray Absorptiometry’ by Cheng et al.	22
The Effect of Anti‐Activin Receptor Type IIA and Type IIB Antibody on Muscle, Bone and Blood in Healthy and Osteosarcopenic Mice	22
Cathelicidin‐related antimicrobial peptide mediates skeletal muscle degeneration caused by injury and Duchenne muscular dystrophy in mice	22
Weight and Blood‐Based Markers of Cachexia Predict Disability, Hospitalization and Worse Survival in Cancer Immunotherapy Patients	22
Stimulator of interferon genes promotes diabetic sarcopenia by targeting peroxisome proliferator activated receptors γ degradation and inhibiting fatty acid oxidation	21
Validity of computed tomography defined body composition as a prognostic factor for functional outcome after kidney transplantation	21
Clinical and prognostic role of sarcopenia in elderly patients with classical Hodgkin lymphoma: a multicentre experience	21
Computed tomography‐defined body composition as prognostic markers for unfavourable outcomes and in‐hospital mortality in coronavirus disease 2019	21
Comment on: ‘Triceps skinfold‐albumin index significantly predicts the prognosis of cancer cachexia: A multicentre cohort study’ by Yin et al.	21
Measured weight loss as a precursor to cancer diagnosis: retrospective cohort analysis of 43 302 primary care patients	21
Impact of anthropometric parameters on outcomes in Asians with metabolic dysfunction‐associated fatty liver disease	21
Geriatric Nutrition Risk Index: Prognostic factor related to inflammation in elderly patients with cancer cachexia	20
	20
Effects of AST‐120 on muscle health and quality of life in chronic kidney disease patients: results of RECOVERY study	20
Prognostic significance of surgery‐induced sarcopenia in the survival of gastric cancer patients: a sex‐specific analysis	20
Analysis of the adiponectin paradox in healthy older people	20
Between‐study differences in grip strength: a comparison of Norwegian and Russian adults aged 40–69 years	20
Cancer anorexia‐cachexia syndrome is characterized by more than one inflammatory pathway	20
Iron accumulation in skeletal muscles of old mice is associated with impaired regeneration after ischaemia–reperfusion damage	20
Effects of correcting metabolic acidosis on muscle mass and functionality in chronic kidney disease: a systematic review and meta‐analysis	20
Call for standardization in assessment and reporting of muscle and adipose change using computed tomography analysis in oncology: A scoping review	20
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series	19
Muscle density is an independent risk factor of second hip fracture: a prospective cohort study	19
Comment on ‘Artificial Neural Network Inference Analysis Identified Novel Genes and Gene Interactions Associated With Skeletal Muscle Aging’ by Tarum et al.	19
Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinoma	19
	19
Three‐year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy	19
Development and early diagnosis of critical illness myopathy in COVID‐19 associated acute respiratory distress syndrome	19
Biomarkers related to fatty acid oxidative capacity are predictive for continued weight loss in cachectic cancer patients	19
Primary skeletal muscle cells from chronic kidney disease patients retain hallmarks of cachexia in vitro	19
Relationships between lung function decline and skeletal muscle and fat mass changes: a longitudinal study in healthy individuals	19
Comment on ‘Change in Physical Activity and Its Association With Decline in Kidney Function: A UK Biobank‐Based Cohort Study’ by Liu et al.	18
Factors associated with handgrip strength across the life course: A systematic review	18
Comment on ‘Bidirectional Transitions of Sarcopenia States in Older Adults: The Longitudinal Evidence From CHARLS’ by Luo et al.	18
Leptin signalling altered in infantile nephropathic cystinosis‐related bone disorder	18
Hepatic signal transducer and activator of transcription‐3 signalling drives early‐stage pancreatic cancer cachexia via suppressed ketogenesis	18
Cachexia causes time‐dependent activation of the inflammasome in the liver	18
Clinical Impact of Sarcopenia Screening on Long‐Term Mortality in Patients Undergoing Coronary Bypass Grafting	18
Plasma microRNA signature associated with skeletal muscle wasting in post‐menopausal osteoporotic women	18
Metagenomic Analysis Identifies Sex‐Related Gut Microbial Functions and Bacterial Taxa Associated With Skeletal Muscle Mass	18
Body composition derangements in lung cancer patients treated with first‐line pembrolizumab: A multicentre observational study	18
Short‐chain fatty acids enhance muscle mass and function through the activation of mTOR signalling pathways in sarcopenic mice	18
	17
	17
Comment on “Causal linkage of tobacco smoking with ageing: Mendelian randomization analysis towards telomere attrition and sarcopenia” by Park et al. — The authors reply	17
Muscle parameters in fragility fracture risk prediction in older adults: A scoping review	17
Metabolic syndrome and cardiovascular disease in cancer survivors	17
Non‐alcoholic fatty liver disease and sarcopenia additively increase mortality: a Korean nationwide survey	17
Comment on ‘Total Magnesium Intake and Risk of Frailty in Older Women’ by Struijk Et Al.	17
GABA Prevents Sarcopenia by Regulation of Muscle Protein Degradation and Inflammaging in 23‐ to 25‐Month‐Old Female Mice	17
Association between dynapenic obesity and risk of cardiovascular disease: The Hisayama study	17
	17
Changes in systemic GDF15 across the adult lifespan and their impact on maximal muscle power: the Copenhagen Sarcopenia Study	17
Gastric inhibitory polypeptide receptor antagonism suppresses intramuscular adipose tissue accumulation and ameliorates sarcopenia	17
Muscle mass versus body mass index as predictor of adverse outcome	17
Metabolomics‐driven discovery of therapeutic targets for cancer cachexia	17
Subcutaneous fat area at the upper thigh level is a useful prognostic marker in the elderly with femur fracture	17
Appendicular lean mass index changes in patients with Duchenne muscular dystrophy and Becker muscular dystrophy	17
Sarcopenia Is a Prognostic Factor of Adverse Effects and Mortality in Patients With Tumour: A Systematic Review and Meta‐Analysis	17
Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria	17
Comment on: “Effects of resistance training intensity on muscle quantity/quality in middle‐aged and older people: a randomized controlled trial” by Otsuka et al.	17
The barriers to interprofessional care for cancer cachexia among Japanese healthcare providers: A nationwide survey	17
Comment on ‘Allograft function and muscle mass evolution after kidney transplantation’ by Gaillard et al.	17
Lack of vitamin D signalling in mesenchymal progenitors causes fatty infiltration in muscle	17
Exercise reduces intramuscular stress and counteracts muscle weakness in mice with breast cancer	17
Comment on ‘AWGC2023 Cachexia Consensus as a Valuable Tool for Predicting Prognosis and Burden in Chinese Patients With Cancer’ by Xie et al.	17
Associations between gut microbiota and sarcopenia or its defining parameters in older adults: A systematic review	17
Differences in the mass and quality of the quadriceps with age and sex and their relationships with knee extension strength	17
Impaired skeletal muscle health in Parkinsonian syndromes: clinical implications, mechanisms and potential treatments	16
Iron Chelation Prevents Age‐Related Skeletal Muscle Sarcopenia in Klotho Gene Mutant Mice, a Genetic Model of Aging	16
How can we design a proper trial for vitamin D treatment of diseases? Facts and numbers	16
Artificial intelligence‐based analysis of body composition predicts outcome in patients receiving long‐term mechanical circulatory support	16
Underweight status and development of end‐stage kidney disease: A nationwide population‐based study	16
Reference Values of Handgrip and Lower Extremity Strength for Vietnamese Men and Women: The Vietnam Osteoporosis Study	16